Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.

An overview of the REDUCE-IT trial of icosapent ethyl for the management of triglycerides and prevention of cardiovascular events.

The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.

The standard of care for managing high cholesterol levels.

The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.